Go Pro

Canopy Growth (CGC) Competitors

Canopy Growth logo
$0.98 -0.02 (-2.00%)
Closing price 09/1/2026 04:00 PM Eastern
Extended Trading
$0.97 -0.01 (-0.52%)
As of 08:42 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

Should you buy Canopy Growth stock or one of its competitors? Canopy Growth's main competitors and comparable companies include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Canopy Growth compare to Aurora Cannabis?

Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Aurora Cannabis
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

Aurora Cannabis has a net margin of -32.26% compared to Canopy Growth's net margin of -65.33%. Aurora Cannabis' return on equity of 4.37% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-65.33% -21.91% -14.34%
Aurora Cannabis -32.26%4.37%3.45%

Aurora Cannabis has higher revenue and earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$293.63M1.49-$190.29M-$0.45N/A
Aurora Cannabis$314.07M0.84-$88.13M-$1.41N/A

In the previous week, Aurora Cannabis had 3 more articles in the media than Canopy Growth. MarketBeat recorded 3 mentions for Aurora Cannabis and 0 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.70 beat Aurora Cannabis' score of 0.19 indicating that Canopy Growth is being referred to more favorably in the media.

Company Overall Sentiment
Canopy Growth Positive
Aurora Cannabis Neutral

Canopy Growth has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.58, indicating that its stock price is 42% less volatile than the broader market.

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.4% of Canopy Growth shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Aurora Cannabis beats Canopy Growth on 9 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Cronos Group?

Canopy Growth (NASDAQ:CGC) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.4% of Canopy Growth shares are held by insiders. Comparatively, 7.8% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Cronos Group has a consensus target price of $2.30, indicating a potential downside of 31.95%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts clearly believe Cronos Group is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Cronos Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

Canopy Growth has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market.

Cronos Group has a net margin of 39.08% compared to Canopy Growth's net margin of -65.33%. Cronos Group's return on equity of 4.85% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-65.33% -21.91% -14.34%
Cronos Group 39.08%4.85%4.62%

Cronos Group has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$293.63M1.49-$190.29M-$0.45N/A
Cronos Group$179.09M7.00-$9.45M$0.2016.90

In the previous week, Cronos Group had 5 more articles in the media than Canopy Growth. MarketBeat recorded 5 mentions for Cronos Group and 0 mentions for Canopy Growth. Cronos Group's average media sentiment score of 1.32 beat Canopy Growth's score of 0.70 indicating that Cronos Group is being referred to more favorably in the news media.

Company Overall Sentiment
Canopy Growth Positive
Cronos Group Positive

Summary

Cronos Group beats Canopy Growth on 15 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Organigram Global?

Canopy Growth (NASDAQ:CGC) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

Organigram Global has a net margin of 28.14% compared to Canopy Growth's net margin of -65.33%. Organigram Global's return on equity of -13.39% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-65.33% -21.91% -14.34%
Organigram Global 28.14%-13.39%-8.67%

Organigram Global has higher revenue and earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$293.63M1.49-$190.29M-$0.45N/A
Organigram Global$309.18M0.54-$17.70M$0.462.57

In the previous week, Organigram Global had 2 more articles in the media than Canopy Growth. MarketBeat recorded 2 mentions for Organigram Global and 0 mentions for Canopy Growth. Organigram Global's average media sentiment score of 1.87 beat Canopy Growth's score of 0.70 indicating that Organigram Global is being referred to more favorably in the news media.

Company Overall Sentiment
Canopy Growth Positive
Organigram Global Very Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Organigram Global
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.4% of Canopy Growth shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Canopy Growth has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market.

Summary

Organigram Global beats Canopy Growth on 12 of the 14 factors compared between the two stocks.

How does Canopy Growth compare to SNDL?

Canopy Growth (NASDAQ:CGC) and SNDL (NASDAQ:SNDL) are related small-cap companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

3.3% of Canopy Growth shares are owned by institutional investors. 0.4% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Canopy Growth has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market. Comparatively, SNDL has a beta of 0.96, indicating that its share price is 4% less volatile than the broader market.

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$293.63M1.49-$190.29M-$0.45N/A
SNDL$677.32M0.52-$11.29M-$0.06N/A

SNDL has a consensus target price of $5.00, indicating a potential upside of 267.65%. Given SNDL's higher probable upside, analysts clearly believe SNDL is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
SNDL
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

SNDL has a net margin of -2.36% compared to Canopy Growth's net margin of -65.33%. SNDL's return on equity of -2.01% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-65.33% -21.91% -14.34%
SNDL -2.36%-2.01%-1.67%

In the previous week, SNDL had 1 more articles in the media than Canopy Growth. MarketBeat recorded 1 mentions for SNDL and 0 mentions for Canopy Growth. SNDL's average media sentiment score of 1.18 beat Canopy Growth's score of 0.70 indicating that SNDL is being referred to more favorably in the news media.

Company Overall Sentiment
Canopy Growth Positive
SNDL Positive

Summary

SNDL beats Canopy Growth on 10 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by company insiders. Comparatively, 0.4% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Tilray Brands has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market.

Tilray Brands has higher earnings, but lower revenue than Canopy Growth. Tilray Brands is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray Brands$210.48M2.91-$121.40M-$1.08N/A
Canopy Growth$293.63M1.49-$190.29M-$0.45N/A

Tilray Brands presently has a consensus price target of $8.00, indicating a potential upside of 77.78%. Given Tilray Brands' stronger consensus rating and higher probable upside, research analysts clearly believe Tilray Brands is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.43
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

Tilray Brands has a net margin of -13.11% compared to Canopy Growth's net margin of -65.33%. Tilray Brands' return on equity of -7.76% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-13.11% -7.76% -5.59%
Canopy Growth -65.33%-21.91%-14.34%

In the previous week, Tilray Brands had 14 more articles in the media than Canopy Growth. MarketBeat recorded 14 mentions for Tilray Brands and 0 mentions for Canopy Growth. Tilray Brands' average media sentiment score of 0.73 beat Canopy Growth's score of 0.70 indicating that Tilray Brands is being referred to more favorably in the media.

Company Overall Sentiment
Tilray Brands Positive
Canopy Growth Positive

Summary

Tilray Brands beats Canopy Growth on 13 of the 16 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CGC vs. The Competition

MetricCanopy GrowthPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market Cap$438.11M$12.06B$7.14B$12.83B
Dividend YieldN/A2.60%2.53%11.78%
P/E Ratio-2.17784.69271.5824.97
Price / Sales1.49791.18606.6383.19
Price / CashN/A92.7077.2052.85
Price / Book0.8811.9612.836.03
Net Income-$190.29M$2.82B$3.47B$348.89M
7 Day Performance-5.79%1.67%-1.03%-2.29%
1 Month Performance6.30%4.69%7.10%2.94%
1 Year Performance-34.56%8.51%23.88%14.08%

Canopy Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CGC
Canopy Growth
0.9505 of 5 stars
$0.98
-2.0%
N/A-45.8%$438.11M$293.63MN/A1,128
ACB
Aurora Cannabis
1.801 of 5 stars
$3.94
flat
N/A-25.3%$255.48M$247.82MN/A1,028
CRON
Cronos Group
1.9411 of 5 stars
$3.41
+3.0%
$2.30
-32.6%
+30.0%$1.23B$146.59M17.05450
OGI
Organigram Global
2.5301 of 5 stars
$1.26
+0.8%
N/A-31.8%$176.22M$185.07M2.741,139
SNDL
SNDL
3.4112 of 5 stars
$1.36
-0.7%
$5.00
+267.6%
-49.3%$352.63M$677.32MN/A2,751

Related Companies and Tools


This page (NASDAQ:CGC) was last updated on 9/2/2026 by MarketBeat.com Staff.
From Our Partners